
    
      -  Participants will receive Darbepoetin alfa through an injection under the skin, about
           28-35 days after their allogeneic stem cell transplant. They will continue to receive
           the study drug once every three weeks for a maximum of four doses.

        -  Blood tests will be performed at weeks 3, 6, 9 and 12. The blood tests done at week
           three will check to make sure the participant has enough iron in their system. If not,
           they will need to take an iron supplement. Participants will also take a folate
           supplement to help cell growth and reproduction.
    
  